Human immunodeficiency virus type 2 - PubMed

Review

Human immunodeficiency virus type 2

Jacqueline D Reeves et al. J Gen Virol. 2002 Jun.

Similar articles

• CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses.

  Borsetti A, Parolin C, Ridolfi B, Sernicola L, Geraci A, Ensoli B, Titti F. Borsetti A, et al. J Virol. 2000 Jul;74(14):6689-94. doi: 10.1128/jvi.74.14.6689-6694.2000. J Virol. 2000. PMID: 10864687 Free PMC article.

• Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.

  Edinger AL, Hoffman TL, Sharron M, Lee B, O'Dowd B, Doms RW. Edinger AL, et al. Virology. 1998 Sep 30;249(2):367-78. doi: 10.1006/viro.1998.9306. Virology. 1998. PMID: 9791028

• Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.

  König RR, Flory E, Steidl S, Neumann J, Coulibaly C, Holznagel E, Holzammer S, Norley S, Cichutek K. König RR, et al. J Virol. 2002 Nov;76(21):10627-36. doi: 10.1128/jvi.76.21.10627-10636.2002. J Virol. 2002. PMID: 12368305 Free PMC article.

• Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry.

  Doms RW, Peiper SC. Doms RW, et al. Virology. 1997 Sep 1;235(2):179-90. doi: 10.1006/viro.1997.8703. Virology. 1997. PMID: 9281497 Review. No abstract available.

• CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo.

  Bhattacharya J, Peters PJ, Clapham PR. Bhattacharya J, et al. AIDS. 2003;17 Suppl 4:S35-43. doi: 10.1097/00002030-200317004-00004. AIDS. 2003. PMID: 15080178 Review. No abstract available.

Cited by

• Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse transcription.

  Post K, Guo J, Howard KJ, Powell MD, Miller JT, Hizi A, Le Grice SF, Levin JG. Post K, et al. J Virol. 2003 Jul;77(13):7623-34. doi: 10.1128/jvi.77.13.7623-7634.2003. J Virol. 2003. PMID: 12805462 Free PMC article.

• Quionolone carboxylic acid derivatives as HIV-1 integrase inhibitors: Docking-based HQSAR and topomer CoMFA analyses.

  Tong J, Zhan P, Wang XS, Wu Y. Tong J, et al. J Chemom. 2017 Dec;31(12):e2934. doi: 10.1002/cem.2934. Epub 2017 Aug 29. J Chemom. 2017. PMID: 29606793 Free PMC article.

• HIV-2 and its role in conglutinated approach towards Acquired Immunodeficiency Syndrome (AIDS) Vaccine Development.

  Diwan B, Saxena R, Tiwari A. Diwan B, et al. Springerplus. 2013 Dec;2(1):7. doi: 10.1186/2193-1801-2-7. Epub 2013 Jan 11. Springerplus. 2013. PMID: 23483108 Free PMC article.

• Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors.

  Prabakaran P, Dimitrov AS, Fouts TR, Dimitrov DS. Prabakaran P, et al. Adv Pharmacol. 2007;55:33-97. doi: 10.1016/S1054-3589(07)55002-7. Adv Pharmacol. 2007. PMID: 17586312 Free PMC article. Review.

• Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.

  Gunaseelan S, Gunaseelan K, Deshmukh M, Zhang X, Sinko PJ. Gunaseelan S, et al. Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):518-31. doi: 10.1016/j.addr.2009.11.021. Epub 2009 Nov 24. Adv Drug Deliv Rev. 2010. PMID: 19941919 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ingenta plc

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information